This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, Z. M. Articles by Baker, C. C. Search for Related Content PubMed PubMed Citation Articles by Zheng, Z. M. Articles by Baker, C. C.

 Previous Article  |  Next Article 

J. Virol., 12 1997, 9096-9107, Vol 71, No. 12
Copyright © 1997, American Society for Microbiology

Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers

ZM Zheng, PJ He and CC Baker
Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-5055, USA. Zhengt@dce41.nci.nih.gov

Alternative splicing plays an important role in regulation of bovine papillomavirus type 1 (BPV-1) gene expression. We have recently identified in BPV-1 late pre-mRNAs two purine-rich exonic splicing enhancers (SE1 and SE2) which also stimulate splicing of a Drosophila doublesex (dsx) pre-mRNA containing a suboptimal 3' splice site. In vivo studies now demonstrate that both SE1 and SE2 are required for preferential use of the BPV-1 nucleotide (nt) 3225 3' splice site in nonpermissive cells. Deletion or mutation of either element in a BPV-1 late pre-mRNA switches splicing to the late-specific alternative 3' splice site at nt 3605. To investigate the sequence specificity of these exonic splicing enhancers, various mutant SE1 or SE2 elements were connected to dsx pre-mRNAs and tested for their stimulatory effects on dsx pre-mRNA splicing in vitro. Substitution of U residues for either A or G residues in and around potential ASF/SF2 binding sites in SE1 or SE2 resulted in a significant reduction of splicing enhancer activity. However, the G-to-U substitutions in both enhancers had the largest effect, reducing splicing to near control levels. Further in vitro analyses showed that splicing enhancement by SE2 could be competed with excess unlabeled SE2 RNA, indicating that SE2 activity in HeLa nuclear extracts is mediated by trans-acting factors. UV cross- linking plus immunoprecipitation assays showed that both wild-type SE1 and SE2 RNAs could bind directly to purified HeLa SR proteins SRp30a (ASF/SF2), SRp55, and SRp75. UV cross-linking experiments also identified a 23-kDa protein which binds to SE2 but not SE1. This protein is present in both HeLa nuclear extracts and S100 extracts but absent from SR protein preparations, suggesting that it is not a classical SR protein. Mutant SE elements (containing G- to U-mutations) which had minimal splicing enhancer activity also had very weak binding capacity for these proteins, strongly suggesting that the binding of these proteins is required for splicing enhancer function.

This article has been cited by other articles:

• Yamanegi, K., Tang, S., Zheng, Z.-M. (2005). Kaposi's Sarcoma-Associated Herpesvirus K8{beta} Is Derived from a Spliced Intermediate of K8 Pre-mRNA and Antagonizes K8{alpha} (K-bZIP) To Induce p21 and p53 and Blocks K8{alpha}-CDK2 Interaction. J. Virol. 79: 14207-14221 [Abstract] [Full Text]  
• Rush, M., Zhao, X., Schwartz, S. (2005). A Splicing Enhancer in the E4 Coding Region of Human Papillomavirus Type 16 Is Required for Early mRNA Splicing and Polyadenylation as Well as Inhibition of Premature Late Gene Expression. J. Virol. 79: 12002-12015 [Abstract] [Full Text]  
• Yang, G., Huang, S.-C., Wu, J. Y., Benz, E. J. Jr (2005). An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer. Blood 105: 2146-2153 [Abstract] [Full Text]  
• Liu, X., Mayeda, A., Tao, M., Zheng, Z.-M. (2003). Exonic Splicing Enhancer-Dependent Selection of the Bovine Papillomavirus Type 1 Nucleotide 3225 3' Splice Site Can Be Rescued in a Cell Lacking Splicing Factor ASF/SF2 through Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway. J. Virol. 77: 2105-2115 [Abstract] [Full Text]  
• Young, P. J., DiDonato, C. J., Hu, D., Kothary, R., Androphy, E. J., Lorson, C. L. (2002). SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2{beta}1. Hum Mol Genet 11: 577-587 [Abstract] [Full Text]  
• DiDonato, C. J., Lorson, C. L., De Repentigny, Y., Simard, L., Chartrand, C., Androphy, E. J., Kothary, R. (2001). Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum Mol Genet 10: 2727-2736 [Abstract] [Full Text]  
• Zheng, Z.-M., Reid, E. S., Baker, C. C. (2000). Utilization of the Bovine Papillomavirus Type 1 Late-Stage-Specific Nucleotide 3605 3' Splice Site Is Modulated by a Novel Exonic Bipartite Regulator but Not by an Intronic Purine-Rich Element. J. Virol. 74: 10612-10622 [Abstract] [Full Text]  
• Hofmann, Y., Lorson, C. L., Stamm, S., Androphy, E. J., Wirth, B. (2000). Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl. Acad. Sci. USA 10.1073/pnas.160181697v1 [Abstract] [Full Text]  
• Zheng, Z.-M., Quintero, J., Reid, E. S., Gocke, C., Baker, C. C. (2000). Optimization of a Weak 3' Splice Site Counteracts the Function of a Bovine Papillomavirus Type 1 Exonic Splicing Suppressor In Vitro and In Vivo. J. Virol. 74: 5902-5910 [Abstract] [Full Text]  
• Lorson, C. L., Androphy, E. J. (2000). An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 9: 259-265 [Abstract] [Full Text]  
• Lai, M.-C., Teh, B. H., Tarn, W.-Y. (1999). A Human Papillomavirus E2 Transcriptional Activator. THE INTERACTIONS WITH CELLULAR SPLICING FACTORS AND POTENTIAL FUNCTION IN PRE-mRNA PROCESSING. J. Biol. Chem. 274: 11832-11841 [Abstract] [Full Text]  
• Zheng, Z. M., He, P.-j., Baker, C. C. (1999). Function of a Bovine Papillomavirus Type 1 Exonic Splicing Suppressor Requires a Suboptimal Upstream 3' Splice Site. J. Virol. 73: 29-36 [Abstract] [Full Text]  
• Zheng, Z. M., Huynen, M., Baker, C. C. (1998). A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. Proc. Natl. Acad. Sci. USA 95: 14088-14093 [Abstract] [Full Text]  
• McNally, L. M., McNally, M. T. (1998). An RNA Splicing Enhancer-Like Sequence Is a Component of a Splicing Inhibitor Element from Rous Sarcoma Virus. Mol. Cell. Biol. 18: 3103-3111 [Abstract] [Full Text]  
• Dirksen, W. P., Li, X., Mayeda, A., Krainer, A. R., Rottman, F. M. (2000). Mapping the SF2/ASF Binding Sites in the Bovine Growth Hormone Exonic Splicing Enhancer. J. Biol. Chem. 275: 29170-29177 [Abstract] [Full Text]  
• Hofmann, Y., Lorson, C. L., Stamm, S., Androphy, E. J., Wirth, B. (2000). Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl. Acad. Sci. USA 97: 9618-9623 [Abstract] [Full Text]